Test Price
1,800 AED✅ Home Collection Available
Breast Cancer BRCA1 & BRCA2 Gene Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary Telephonic Post-Test Genetic Counselling to interpret your BRCA report with a DHA-licensed physician.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 before sample collection.
Multilingual genetic counselling available upon request; report delivered in English with clinical annotations.
Test Overview & Methodology
This advanced Next-Generation Sequencing (NGS) test evaluates the full coding regions of BRCA1 and BRCA2 for inherited pathogenic variants linked to hereditary breast, ovarian, prostate, and pancreatic cancer syndromes.
| Feature | Our Test (NGS Full Gene Analysis) | Standard Alternative (PCR Limited Panel) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) – covers all exons, splice sites, and large rearrangements | Allele-specific PCR or targeted genotyping for a few founder mutations |
| Detection Scope | Point mutations, small insertions/deletions, and copy number variants (CNVs) | Limited to pre-selected mutations; misses novel or rare variants |
| Clinical Utility | Comprehensive risk assessment, eligibility for PARP inhibitors, and cascade family testing | Basic risk stratification, often requiring reflex to full sequencing if negative |
| Sample Type | Blood EDTA tube (home collection available) | Blood or buccal swab (limited logistics) |
| Turnaround Time | 3 weeks | 2–3 weeks |
| Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), DHA/MOHAP compliant | Variable; often without UAE-specific regulatory oversight |
| Price | 2800 AED | 2,200–2,600 AED (may not include counselling) |
Physician Insight & Safety Protocols
“As a medical geneticist, I understand the emotional weight of genetic testing for cancer predisposition. A positive result does not mean a cancer diagnosis; it indicates a manageable increased risk that empowers you with proactive surveillance and prevention options. My clinical team, including genetic counsellors, will support you throughout the journey to interpret results and plan personalised care.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⛔ Critical Advisory
Do not discontinue any prescribed medication (e.g., hormonal therapies, chemotherapy) without consulting your treating physician. Genetic test results must be interpreted in the full clinical context, and treatment changes should only be made by a licensed oncologist.
Exclusion Criteria & Red Flags
- Exclusion: Acute febrile illness or active infection (defer testing until resolved).
- Exclusion: Inability to provide valid informed consent (guardian required for minors as per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Exclusion: Known coagulopathy or severe thrombocytopenia contraindicating venipuncture; alternative buccal sample not offered for this genetic assay.
- Emergency Red Flag: If you experience acute psychological distress, suicidal ideation, or overwhelming anxiety related to genetic testing, seek immediate mental health support before proceeding.
- Emergency Red Flag: A personal history of breast/ovarian cancer with rapidly worsening symptoms; prioritise oncology consultation, not elective genetic testing.
Patient FAQ & Clinical Guidance
1. What exactly does the BRCA1/BRCA2 gene test detect?
The test identifies inherited harmful mutations in the BRCA1 and BRCA2 genes that significantly elevate the lifetime risk of developing breast, ovarian, prostate, and pancreatic cancers.
2. How is the sample collected and when will I receive my results?
A certified phlebotomist draws a single blood EDTA tube at your home within our 8 AM–11 PM slot, and following NGS analysis in our ISO‑certified lab, a comprehensive report with genetic counselling is delivered in 3 weeks.
3. Will my UAE health insurance cover this BRCA test?
Coverage depends on your policy’s preventive care provisions; we provide a free direct billing verification service via WhatsApp at +971 54 548 8731 before your appointment to confirm eligibility without upfront payment.
UAE Regulatory & Data Privacy Adherence
Your Data, Your Rights
All genetic data processing complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your results are encrypted, access-controlled, and never shared without explicit consent.
Clinical & Logistical Metadata
| Test Name | Breast Cancer BRCA1 & BRCA2 Gene Test |
| Price (AED) | 2800 |
| Turnaround Time | 3 weeks |
| Sample Type / Matrix | Blood EDTA tube |
| Methodology Used | Next-Generation Sequencing (NGS) – full gene analysis covering all exons, splice sites, and large rearrangements |
| ICD-10-CM Code | Z15.01 |
| LOINC Code | 94215-7 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians